194 related articles for article (PubMed ID: 28052946)
21. Epistaxis and dabigatran, a new non-vitamin K antagonist oral anticoagulant.
García Callejo FJ; Bécares Martínez C; Calvo González J; Martínez Beneyto P; Marco Sanz M; Marco Algarra J
Acta Otorrinolaringol Esp; 2014; 65(6):346-54. PubMed ID: 24958185
[TBL] [Abstract][Full Text] [Related]
22. Dabigatran and vitamin K antagonists' use in naïve patients with non-valvular atrial fibrillation: a cross-sectional study of primary care-based electronic health records.
Vlacho B; Giner-Soriano M; Zabaleta-Del-Olmo E; Roso-Llorach A; García-Sangenís A; Morros-Pedrós R
Eur J Clin Pharmacol; 2017 Oct; 73(10):1323-1330. PubMed ID: 28725983
[TBL] [Abstract][Full Text] [Related]
23. Chronic iritis associated with cutaneous leukocytoclastic vasculitis.
Lambert J; Rodriguez A; Pearcy-Baluyot M; Shahi SK
Mil Med; 2015 May; 180(5):e622-5. PubMed ID: 25939124
[TBL] [Abstract][Full Text] [Related]
24. Dabigatran-Associated Thrombocytopenia.
Rafiullah ; de Magalhaes-Silverman M; Perepu U
Am J Ther; 2018; 25(6):e701-e704. PubMed ID: 30403387
[No Abstract] [Full Text] [Related]
25. [Antibiotics, purpura and ulcers: a leukocytoclastic vasculitis after clarithromycin].
Zink A; Erni S; Fliegner M
Dtsch Med Wochenschr; 2006 Oct; 131(40):2217-20. PubMed ID: 17021990
[TBL] [Abstract][Full Text] [Related]
26. Leukocytoclastic vasculitis complicating cisplatin + radiation treatment for laryngeal cancer: a case report.
Quintanilha JCF; Visacri MB; Amaral LS; Lima CSP; Cintra ML; Moriel P
BMC Cancer; 2017 Dec; 17(1):831. PubMed ID: 29212535
[TBL] [Abstract][Full Text] [Related]
27. An Unusual Case of Apixaban-Induced Small Vessel Vasculitis: Leukocytoclastic Vasculitis.
Adebayo AY; Ali A; Goswami RM; Abimbolu O; Nayab K; Onyemarim H
Cureus; 2024 Feb; 16(2):e55040. PubMed ID: 38550439
[TBL] [Abstract][Full Text] [Related]
28. New algorithm (KAWAKAMI algorithm) to diagnose primary cutaneous vasculitis.
Kawakami T
J Dermatol; 2010 Feb; 37(2):113-24. PubMed ID: 20175844
[TBL] [Abstract][Full Text] [Related]
29. Successful hemostasis and reversal of highly elevated PT/INR after dabigatran etexilate use in a patient with acute kidney injury.
Jones JM; Ryan HM; Tieszen M; Leedahl DD
Am J Emerg Med; 2016 Apr; 34(4):758.e5-6. PubMed ID: 26324007
[TBL] [Abstract][Full Text] [Related]
30. Ibuprofen-induced bullous leukocytoclastic vasculitis.
Davidson KA; Ringpfeil F; Lee JB
Cutis; 2001 Apr; 67(4):303-7. PubMed ID: 11324392
[TBL] [Abstract][Full Text] [Related]
31. Dabigatran-Induced Spontaneous Hemopericardium and Cardiac Tamponade.
Jelani QU; Gordon R; Schussheim A
Tex Heart Inst J; 2017 Oct; 44(5):370-372. PubMed ID: 29259514
[TBL] [Abstract][Full Text] [Related]
32. [First manifestation of a leucocytoclastic vasculitis in the colon: case report and differential diagnostic aspects].
Schartner E; Höflmayer D; Müller-Knespel EM; Dzirlo L; Haunold I; Dawid M; Stanek-Kalchhauser D; Weiss P; Klimpfinger M
Z Gastroenterol; 2013 Jan; 51(1):37-42. PubMed ID: 23315650
[TBL] [Abstract][Full Text] [Related]
33. A case of severe vasculitis after FLOT chemotherapy in a patient with metastatic gastric cancer who received multiple line chemotherapy.
Hendem E; Korkmaz M; Uğraklı M; Karakurt Eryılmaz M; Karaağaç M; Araz M; Artaç M
J Oncol Pharm Pract; 2022 Jul; 28(5):1222-1225. PubMed ID: 35044279
[TBL] [Abstract][Full Text] [Related]
34. Reversing the anticoagulation effects of dabigatran.
Dager WE; Banares L
Hosp Pract (1995); 2017 Apr; 45(2):29-38. PubMed ID: 28335637
[TBL] [Abstract][Full Text] [Related]
35. [Thrombosis of a mechanical prosthetic mitral valve during dabigatran treatment].
Thomsen JH; Kjaergaard J; Saust LT; Wachtell K; Hassager C
Ugeskr Laeger; 2014 Mar; 176(12A):. PubMed ID: 25350892
[TBL] [Abstract][Full Text] [Related]
36. Management of Dabigatran-Associated Bleeding with Two Doses of Idarucizumab Plus Hemodialysis.
Marino KK; Santiago RA; Dew RB; Berliner N; Connors JM; Connell NT; Tucker JK
Pharmacotherapy; 2016 Oct; 36(10):e160-e165. PubMed ID: 27581709
[TBL] [Abstract][Full Text] [Related]
37. Assessment of Predicted Rate and Associated Factors of Dabigatran-induced Bleeding Events in Malaysian Patients with Non-Valvular Atrial Fibrillation.
Beshir SA; Yap LB; Sim S; Chee KH; Lo YL
J Pharm Pharm Sci; 2017; 20(1):365-377. PubMed ID: 29145930
[TBL] [Abstract][Full Text] [Related]
38. Rationale and design of the RE-LATED AF--AFNET 7 trial: REsolution of Left atrial-Appendage Thrombus--Effects of Dabigatran in patients with Atrial Fibrillation.
Ferner M; Wachtlin D; Konrad T; Deuster O; Meinertz T; von Bardeleben S; Münzel T; Seibert-Grafe M; Breithardt G; Rostock T
Clin Res Cardiol; 2016 Jan; 105(1):29-36. PubMed ID: 26109251
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.
Yao X; Abraham NS; Sangaralingham LR; Bellolio MF; McBane RD; Shah ND; Noseworthy PA
J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27412905
[TBL] [Abstract][Full Text] [Related]
40. Orlistat-induced bullous leukocytoclastic vasculitis.
Lazic T; Fonder M; Robinson-Bostom L; Wilkel CS; Della Torre L
Cutis; 2013 Mar; 91(3):148-9. PubMed ID: 23617088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
